The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Osteonecrosis of the jaw (ONJ) in patients with metastatic castration resistant prostate cancer (mCRPC) treated with denosumab in a randomized phase III trial comparing 4 vs. 12 weekly administration (REDUSE, SAKK 96/12).
 
Arnoud Templeton
Honoraria - Bayer (Inst); Janssen
Consulting or Advisory Role - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb/Pfizer (Inst); Ipsen (Inst); Merck; MSD; MSD (Inst); Pfizer (Inst); Pfizer (Inst); Sandoz (Inst)
Travel, Accommodations, Expenses - Orion Health; Roche
 
Stefanie Hayoz
No Relationships to Disclose
 
Simone Wyss-Neyer
No Relationships to Disclose
 
Richard Cathomas
Honoraria - Astellas Pharma (Inst); Janssen-Cilag; Merck KGaA (Inst); Sandoz (Inst)
Consulting or Advisory Role - Accord Healthcare (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Ipsen (Inst); Janssen-Cilag; MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Ipsen (Inst)
 
Ricardo Pereira Mestre
No Relationships to Disclose
 
Christian Rothermundt
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); IPSEN (Inst); MSD Oncology (Inst); Pfizer (Inst)
Expert Testimony - MSD Oncology (Inst)
Travel, Accommodations, Expenses - Bayer (Inst)
 
Sandro Anchisi
No Relationships to Disclose
 
Christoph Ackermann
Consulting or Advisory Role - MSD (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Katharina Reichel
Consulting or Advisory Role - Astellas Pharma; Bayer; BMS GmbH & Co. KG (Inst); MSD Oncology; Novartis (Inst)
Speakers' Bureau - Astellas Pharma; Bayer; Janssen
Travel, Accommodations, Expenses - Bayer; Janssen
 
Beat Mueller
No Relationships to Disclose
 
Claudine Egger
No Relationships to Disclose
 
Augusto Pedrazzini
No Relationships to Disclose
 
Razvan Popescu
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Janssen-Cilag (Inst); Kaiku Health (Inst); Lilly (Inst); Merck (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Vifor Pharma (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Kaiku Health (Inst); Lilly (Inst); Novartis (Inst); Pierre Fabre (Inst); Roche (Inst); Sanofi (Inst)
 
Lena Züllig
Consulting or Advisory Role - Bayer
Travel, Accommodations, Expenses - Bayer; Janssen Oncology
 
Regina Woelky
Travel, Accommodations, Expenses - Roche
 
Priska Bützberger
No Relationships to Disclose
 
Florian Schmid
No Relationships to Disclose
 
Roger Von Moos
Honoraria - Deciphera; Lilly; Pfizer; Pierre Fabre
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; InnoMedica; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; PharmaMar; Roche; Seagan; Vifor Pharma
Expert Testimony - Seagen
Travel, Accommodations, Expenses - Takeda
 
Silke Gillessen
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo Europe GmbH (Inst); InnoMedica (Inst); Ipsen (Inst); Macrogenics (Inst); MSD Oncology (Inst); Myriad Genetics (Inst); Novartis (Inst); PeerVoice (Inst); Pfizer (Inst)
Speakers' Bureau - AdMeTech Foundation (Inst); ASCO GU (Inst); Avalere Health (Inst); EPG Health (Inst); ESMO; German-speaking European School of Oncology (DESO); Intellisphere (Inst); Meister ConCept GmbH (Inst); Schweizerische Gesellschaft für Medizinische Onkologie; Silvia Grasso Consulting (Inst); Swiss Group for Clinical Cancer Research (SAKK); Swiss Group for Clinical Cancer Research (SAKK) (Inst)
Patents, Royalties, Other Intellectual Property - Method for biomarker (WO 3752009138392 A1)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Gilead Sciences; Intellisphere